Report by MYST Advisors

Short-focused events consistently rank among MYST’s best-performing Idea Forums with their last one yielding a ~70% hit rate and ~8.7% average positive alpha. The dominant theme at this meeting centred on companies confronting new competition driving share loss and margin compression, while other high-level topics included businesses facing AI-related challenges; “fading” cyclical recoveries; and GLP-1-driven demand destruction. MYST felt Calix (BEAD subsidy unwind favours lower-cost solutions + forensic red flags) and TransMedics (organ transplant tech leader facing share loss amid new competition) were “unique” and worth investigating, while convincing bearish arguments were also presented on A.O. Smith, Dollar General, Old Dominion Freight Line and Uber.

Technology

Short thesis based on margin sustainability concerns and earnings quality issues - Gradient’s 12-page report focuses on 1) Smaller customers driving growth (increases risk of surprise sales declines from customer hardship). 2) Believes management may have pulled levers to optically improve operating margin. 3) Inventory has surged ahead of supply-chain threats. 4) Accrued expenses benefited TTM operating profit but could turn to a headwind. 5) Capitalised costs have surged. 6) Valuation metrics leave room for further downside.

Technology

Report by BWS Financial

Priced for perfection despite signs of growth waning - overly bullish management forecasts to leave investors disappointed. CALX has benefitted from an increase in broadband service providers adopting its software solutions during a time when people were staying at home, but those trends are now changing. Comcast and Altice USA have both recently reported a decline in broadband subscribers and Hamed Khorsand believes CALX’s customer concentration towards smaller providers makes it prone to even greater volatility with orders. 12-month TP $13 (75% downside).